Goto Yasufumi, Arigami Takaaki, Kitago Minoru, Nguyen Sandy L, Narita Norihiko, Ferrone Soldano, Morton Donald L, Irie Reiko F, Hoon Dave S B
Department of Molecular Oncology, John Wayne Cancer Institute, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA.
Mol Cancer Ther. 2008 Nov;7(11):3642-53. doi: 10.1158/1535-7163.MCT-08-0582.
Toll-like receptors (TLR) have been shown to be expressed on various types of cancers; however, their functional activity is not known. We examined TLR profiles of human melanoma cells and showed that TLR2, TLR3, and TLR4 were found to be highly expressed. By PCR array analysis, specific stimulation of TLR2, TLR3, and TLR4 on melanoma cells showed significant activation of the adaptor protein MyD88, as well as downstream signal transduction factors nuclear factor-kappaB and inflammatory response-related factors. Specific ligand activation of TLR2, TLR3, and TLR4 was shown to induce cell migration. Peripheral blood lymphocytes and melanoma purified RNA was shown to activate TLR3 on melanoma cells. These studies show expression and functional activity of specific TLRs on melanoma cells and as potential therapeutic targets to control tumor progression.
Toll样受体(TLR)已被证明在各种类型的癌症中表达;然而,它们的功能活性尚不清楚。我们检测了人黑色素瘤细胞的TLR谱,发现TLR2、TLR3和TLR4高表达。通过PCR阵列分析,黑色素瘤细胞上TLR2、TLR3和TLR4的特异性刺激显示衔接蛋白MyD88以及下游信号转导因子核因子-κB和炎症反应相关因子的显著激活。TLR2、TLR3和TLR4的特异性配体激活被证明可诱导细胞迁移。外周血淋巴细胞和黑色素瘤纯化RNA被证明可激活黑色素瘤细胞上的TLR3。这些研究表明特定TLR在黑色素瘤细胞上的表达和功能活性,以及作为控制肿瘤进展的潜在治疗靶点。